Ahabir 250mg Tablet
Rx RequiredSalt Composition: Abiraterone Acetate
Expiry Date: 01/2028
Buy at $149.29
Inclusive of all taxes
120 Tablet in Bottle
About The Product
Prostate Cancer
Ahabir 250mg Tablet is a prescription-based anticancer drug used in the treatment of metastatic, castration-resistant prostate cancer. The prostate is a gland present in the male reproductive system. This anticancer medicine is sometimes given with certain other medications as part of a combination drug in chemotherapy to increase its effectiveness. Ahabir Tablets should not given to people allergic to abiraterone and those who are suffering from severe liver disease.
Description
Ahabir 250mg Tablet belongs to a group of medicines called Androgen biosynthesis inhibitors. The active constituent of this anticancer medicine is abiraterone acetate.
It is given to adult men to treat metastatic, castration-resistant prostate cancer, which has already spread to other parts of the body. It is usually given in combination with other steroid medication to reduce the chances of side effects.
Ahabir 250mg Tablet should be taken with or without food as doctor's prescription. Ahabir Tablet is given for an early stage of prostate cancer with testosterone-lowering treatment.
This medicine should not be given to women or children without consulting a healthcare expert. As Ahabir 250mg Tablet has lactose and sodium, inform your physician if you're lactose intolerant or on a salt control diet.
The exact dosage and frequency of taking the medicine are decided by your doctor. Taking it inappropriately or overdosing can cause severe side effects.
Side Effects
Most side effects experienced after taking Ahabir 250mg Tablet do not need any medical help as they do not appear with time. The human body starts adapting to the medicine. Consult your doctor if they become hard to handle. Some of them are listed below:
Common side effects
Swelling in legs or feet
High blood pressure
Urinary tract infection
Diarrhea, indigestion
Chest pain, irregular heartbeat, rapid heart rate
Bone fractures
Blood in urine
Decreased potassium level in blood
Severe and rare side effects
Sepsis
Abnormal heart rhythm
Muscle weakness/pain
Lung irritation (allergic alveolitis)
Adrenal insufficiency (a disorder in which the adrenal glands won't be able to produce enough hormones)
How To Use
- Ahabir 250mg Tablet is a prescription-based anticancer drug that should be administered orally.
- It is advised to take this tablet after consulting your healthcare expert.
How It Works
Ahabir 250mg Tablet is an anticancer medication used for treating prostate cancer. This medicine works by preventing androgen (male hormone) production in males.
It inhibits an enzyme known as CYP17, which is responsible for androgen production. This process slows down the multiplication rate and stops the progression of prostate cancer.
Safety Advice
Missed Doses
- It is advised not to miss any scheduled dosage of Ahabir 250mg Tablet.
- In case you miss a dose, consult your doctor immediately.
- Don't overdose to compensate for the missed one.
- Contact your doctor or any healthcare provider and seek medical attention immediately in such cases.
Quick Tips
Ahabir 250mg Tablet is usually taken with another medicine called prednisolone to reduce the unwanted side effects.
It is advised to use effective birth control measures to prevent pregnancy while taking Ahabir 250mg Tablet.
It is important to monitor your liver function, blood pressure, and the potassium level in your blood regularly when undergoing treatment with Ahabir 250mg Tablet.
FAQs
Ahabir 250mg Tablet does not cure cancer completely in the human body but helps in improving the quality of life of the patient.
Moreover, when prostate cancer is treated with this tablet, then the rate of fractures is relatively less, and the increase in pain is also less common.
Reference
Acharya, M., Bernard, A., Gonzalez, M., Jiao, J., De Vries, R., & Tran, N. (2022).
Open-label, phase I, pharmacokinetic studies of abiraterone acetate in healthy men. Cancer chemotherapy and pharmacology, 69(6), 1583-1590.
Prati, V., Ruatta, F., Aversa, C., Gernone, A., Galizia, D., Bonzano, A. & Ortega, C. (2024).
Cardiovascular safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients: a prospective evaluation. Future Oncology, 14(5), 443-448.
Procopio G, Grassi P, Testa I, Verzoni E, Torri V, Salvioni R, Valdagni R, de Braud F. (2024).
Safety of Abiraterone Acetate in Castration-resistant Prostate Cancer Patients With Concomitant Cardiovascular Risk Factors. Am J Clin Oncol.
38(5):479-82. Tan, G., Xuan, Z., Li, Z., Huang, S., Chen, G., Wu, Y.& Wu, A.
(2023). The efficacy and safety of abiraterone acetate in patients with high-risk prostate cancer: a meta-analysis based on six randomized controlled trials.
Translational Andrology and Urology, 9(4), 1691. Verzoni, E., Grassi, P., Ratta, R., Niger, M., De Braud, F., Valdagni, R., & Procopio, G.
(2025). Safety of long-term exposure to abiraterone acetate in patients with castration-resistant prostate cancer and concomitant cardiovascular risk factors.
Therapeutic advances in medical oncology, 8(5), 323-330.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
.png&w=48&q=75 "Cart"){kind=small}
9655.png&w=48&q=75 "Home"){kind=small}
